(2S,3S,4R,5R,6S)-2-[(2R)-4-[(1S,2S,4S,6R,7S,8R,9S,12S,13R,15R,16R)-16-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-hydroxy-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Details

Top
Internal ID 0779d178-345f-452e-8e0c-1be819da8c11
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Steroidal glycosides > Steroidal saponins
IUPAC Name (2S,3S,4R,5R,6S)-2-[(2R)-4-[(1S,2S,4S,6R,7S,8R,9S,12S,13R,15R,16R)-16-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-hydroxy-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
SMILES (Canonical) CC1C2C(CC3C2(CCC4C3CC=C5C4(CC(C(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)CO)O)OC8C(C(C(CO8)O)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)O)C)C)OC1(CCC(C)COC1C(C(C(C(O1)CO)O)O)O)OC
SMILES (Isomeric) C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(C[C@H]([C@@H](C5)O[C@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O[C@H]8[C@@H]([C@H]([C@@H](CO8)O)O)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O)O)O)C)C)O[C@@]1(CC[C@@H](C)CO[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)CO)O)O)O)OC
InChI InChI=1S/C57H94O29/c1-21(19-76-50-44(72)40(68)37(65)31(15-58)79-50)8-11-57(75-5)22(2)35-30(86-57)13-26-24-7-6-23-12-29(27(62)14-56(23,4)25(24)9-10-55(26,35)3)78-52-46(74)42(70)47(34(18-61)82-52)83-54-49(85-53-45(73)41(69)38(66)32(16-59)80-53)48(39(67)33(17-60)81-54)84-51-43(71)36(64)28(63)20-77-51/h6,21-22,24-54,58-74H,7-20H2,1-5H3/t21-,22+,24-,25+,26+,27-,28-,29-,30+,31+,32-,33-,34-,35+,36+,37+,38-,39-,40-,41+,42-,43-,44+,45-,46-,47+,48+,49-,50+,51+,52-,53+,54+,55+,56+,57-/m1/s1
InChI Key BZKDZZLBNBAVJH-ZNVWQKHBSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C57H94O29
Molecular Weight 1243.30 g/mol
Exact Mass 1242.58807696 g/mol
Topological Polar Surface Area (TPSA) 455.00 Ų
XlogP -4.20
Atomic LogP (AlogP) -5.95
H-Bond Acceptor 29
H-Bond Donor 17
Rotatable Bonds 19

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2S,3S,4R,5R,6S)-2-[(2R)-4-[(1S,2S,4S,6R,7S,8R,9S,12S,13R,15R,16R)-16-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-5-[(2S,3R,4S,5R,6R)-5-hydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-hydroxy-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7474 74.74%
Caco-2 - 0.8787 87.87%
Blood Brain Barrier - 0.7000 70.00%
Human oral bioavailability - 0.8286 82.86%
Subcellular localzation Mitochondria 0.7129 71.29%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8608 86.08%
OATP1B3 inhibitior + 0.9262 92.62%
MATE1 inhibitior - 0.9612 96.12%
OCT2 inhibitior - 0.6250 62.50%
BSEP inhibitior + 0.9018 90.18%
P-glycoprotein inhibitior + 0.7429 74.29%
P-glycoprotein substrate + 0.7315 73.15%
CYP3A4 substrate + 0.7591 75.91%
CYP2C9 substrate - 0.8025 80.25%
CYP2D6 substrate - 0.8264 82.64%
CYP3A4 inhibition - 0.9441 94.41%
CYP2C9 inhibition - 0.9179 91.79%
CYP2C19 inhibition - 0.9105 91.05%
CYP2D6 inhibition - 0.9346 93.46%
CYP1A2 inhibition - 0.9105 91.05%
CYP2C8 inhibition + 0.7740 77.40%
CYP inhibitory promiscuity - 0.9390 93.90%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.5094 50.94%
Eye corrosion - 0.9891 98.91%
Eye irritation - 0.9013 90.13%
Skin irritation - 0.5613 56.13%
Skin corrosion - 0.9417 94.17%
Ames mutagenesis - 0.8678 86.78%
Human Ether-a-go-go-Related Gene inhibition + 0.8639 86.39%
Micronuclear - 0.8500 85.00%
Hepatotoxicity - 0.8033 80.33%
skin sensitisation - 0.9128 91.28%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.9333 93.33%
Mitochondrial toxicity + 0.5625 56.25%
Nephrotoxicity - 0.9236 92.36%
Acute Oral Toxicity (c) I 0.5855 58.55%
Estrogen receptor binding + 0.8598 85.98%
Androgen receptor binding + 0.7427 74.27%
Thyroid receptor binding + 0.5573 55.73%
Glucocorticoid receptor binding + 0.6962 69.62%
Aromatase binding + 0.6716 67.16%
PPAR gamma + 0.8111 81.11%
Honey bee toxicity - 0.5627 56.27%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity - 0.5600 56.00%
Fish aquatic toxicity + 0.8517 85.17%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 98.99% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.63% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 98.04% 95.93%
CHEMBL218 P21554 Cannabinoid CB1 receptor 94.91% 96.61%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.64% 97.09%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 94.26% 94.45%
CHEMBL1994 P08235 Mineralocorticoid receptor 92.11% 100.00%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 91.87% 94.08%
CHEMBL2955 O95136 Sphingosine 1-phosphate receptor Edg-5 88.54% 92.86%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 87.95% 95.89%
CHEMBL5608 Q16288 NT-3 growth factor receptor 87.91% 95.89%
CHEMBL253 P34972 Cannabinoid CB2 receptor 87.00% 97.25%
CHEMBL3359 P21462 Formyl peptide receptor 1 86.65% 93.56%
CHEMBL1914 P06276 Butyrylcholinesterase 86.61% 95.00%
CHEMBL3401 O75469 Pregnane X receptor 86.61% 94.73%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 86.21% 89.05%
CHEMBL2581 P07339 Cathepsin D 85.61% 98.95%
CHEMBL4581 P52732 Kinesin-like protein 1 85.16% 93.18%
CHEMBL3892 Q99500 Sphingosine 1-phosphate receptor Edg-3 85.04% 97.29%
CHEMBL5255 O00206 Toll-like receptor 4 84.81% 92.50%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 84.75% 91.24%
CHEMBL2996 Q05655 Protein kinase C delta 83.93% 97.79%
CHEMBL1293249 Q13887 Kruppel-like factor 5 83.88% 86.33%
CHEMBL221 P23219 Cyclooxygenase-1 83.77% 90.17%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 83.52% 97.14%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 82.77% 92.88%
CHEMBL237 P41145 Kappa opioid receptor 82.01% 98.10%
CHEMBL2360 P00492 Hypoxanthine-guanine phosphoribosyltransferase 81.98% 87.38%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 81.90% 96.00%
CHEMBL3713062 P10646 Tissue factor pathway inhibitor 81.07% 97.33%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 80.74% 100.00%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 80.63% 95.50%
CHEMBL2335 P42785 Lysosomal Pro-X carboxypeptidase 80.29% 100.00%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.12% 89.00%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Allium karataviense

Cross-Links

Top
PubChem 163042691
LOTUS LTS0054081
wikiData Q104950507